tirzepatide clinical trials Cardiovascular outcomes of semaglutide and for patients with type 2 diabetes in practice Tirzepatide: A Systematic Update

Patients should seek urgent medical attention if they experience signs of a severe allergic reaction (such as widespread rash, facial or tongue swelling, or breathing difficulties) or extensive skin reactions

2000 Feb;6(3):311-25

Acknowledgment The authors acknowledge all the doctors who participated in the advisory board meetings, which were instrumental in developing the recommendations and final manuscript

Perhaps most striking, the SURMOUNT-4 maintenance trial showed that stopping tirzepatide led to significant weight regain

(With off-label use, a doctor prescribes you medication for different purposes than its approved uses.) Zepbound also contains tirzepatide and is FDA approved for weight loss and weight management